Refine by
Drug Development Processes Articles & Analysis
54 news found
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the ...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the expansion and enhancement of its comprehensive Drug Discovery Services to help scientists advance antiviral therapeutic development, including target selection and validation, hit selection and optimization, and preclinical ...
Key Product Highlights: · PEG Derivatives o A vast inventory of over 3000 high-quality PEG derivatives. o Monodispersed PEG linkers and multi-arm PEGs. o Scalable production from R&D to GMP commercial levels. o Applications spanning ADCs, PROTACs, LNP drug delivery, medical devices, and more. · Pharmaceutical Intermediates o Comprehensive ...
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology ...
As the prevalence of diabetes continues to rise, there is an urgent need for advanced research models that can accurately simulate the disease and facilitate the development of effective interventions. Ace Therapeutics’ in vivo models such as diabetes spontaneous models are made to mimic the pathophysiological characteristics of Type 1 and Type 2 diabetes mellitus, ...
In medical applications, they’re used in cancer therapies and viral infection drugs. Alfa Chemistry makes this possible by providing pure and highly diverse nucleosides with modified versions used in the development of oligonucleotide therapeutics. ...
Through the utilization of cutting-edge computational chemistry techniques, CD ComputaBio aims to streamline and enhance the process of drug discovery for pharmaceutical companies, research institutions, and biotech firms. ...
Chemical Diversity - The vast chemical space of small molecules provides opportunities for lead optimization and the development of novel drug candidates. Regulatory Success - Small molecules have a well-established regulatory pathway, facilitating the approval and commercialization process. Areas covered by our small molecule ...
Factors like drug release kinetics, absorption, metabolism, and possible toxicity during the preclinical stage would be assessed. ...
In the pharmaceutical industry, this field plays a critical role in drug development, as the solid form of a drug can significantly impact its performance, bioavailability, and stability. ...
The screening of substrates, inhibitors, and other ligands is a pivotal facet of enzyme research, enabling scientists to pinpoint compounds best suited for a variety of applications, from drug development to industrial processes. A profound understanding of enzyme-molecule interactions can pave the way for groundbreaking therapies, improved ...
Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of 3D bioprinted tumor models based on cancer cell lines that improve accuracy and rapidly speed up drug development processes, driving down development costs and enabling an ...
ByCELLINK
Our team recognizes this need and has developed a suite of services to support drug development at its earliest stages. ...
CD ComputaBio prides itself on a team of experienced professionals and advanced technology, delivering tailored Drug Design services to its clients. Through the utilization of sophisticated computational tools and algorithms, the company's experts expedite the drug development process. ...
The service can help clients address these issues by providing accurate predictions of drug molecule interactions, optimizing drug molecule design, improving drug safety and efficacy, and accelerating drug development. “Protein-small molecule docking is a critical step in the drug ...
“Our analysis and testing services will support pharmaceutical companies at every step and phase of the drug development lifecycle, making sure the entire drug development process complies with the latest regulatory standards and ...
“Drug development today is a time-consuming and expensive process - it can take a decade or longer to take a new drug to market and cost hundreds of millions of dollars,” said Brian Battey, COO of Cellworks Group. ...
“Throughout the manufacturing process, we focus extensively on the safety of API production on the one hand and pay attention to ensure all quality standards and cGMP requirements are met on the ...
Pronalyse is a subdivision of Creative Proteomics, an integrated CRO company with rich experience in providing drug development services. Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its fusion proteins characterization service to ensure the production of safe and effective therapeutic fusion proteins. Fusion protein refers to a new type of synthetic ...
Management will discuss the Company’s neuroscience and immuno-oncology programs as well as its artificial intelligence platform used to augment and accelerate the drug candidate discovery and development process. They will also discuss the Company’s ongoing commercial launch strategy for IGALMI™ (dexmedetomidine) sublingual ...